Healthcare / Medical Care FacilitiesHKSE
$0.12
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-10.0M · quality 49.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
28/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$68M
P/E
N/A
•EV/EBITDA
2.7x
↓ROE
1.7%
↑Gross Margin
41.0%
↓Debt/Equity
0.55
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2025 · 4 años de histórico normalizado
Revenue CAGR
+0.1%
FCF CAGR
—
FCF margin
13.0%
FCF / Net income
13.14x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $189.4M · net income $1.9M · FCF $24.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | $189.4M | $189.4M | $199.3M | $189.4M | $164.5M | $188.4M |
| Net Income | $1.9M | $1.9M | $-59.2M | $-32.5M | $-15.9M | $-17.7M |
| EBITDA | $25.3M | $25.3M | $-34.3M | $-6.0M | $3.9M | $-6.0M |
| EPS | — | — | -0.11 | -0.34 | -0.03 | -0.04 |
| Gross Margin | 41.0% | 41.0% | 35.8% | 37.8% | 40.6% | 37.0% |
| Operating Margin | 3.5% | 3.5% | -9.4% | -11.9% | -12.3% | -10.2% |
| Net Margin | 1.0% | 1.0% | -29.7% | -17.1% | -9.7% | -9.4% |
| Balance Sheet | ||||||
| Debt/Equity | 0.55 | 0.55 | 0.54 | 0.37 | 0.29 | 0.38 |
| Current Ratio | 0.77 | 0.77 | — | — | — | — |
| Cash Flow | ||||||
| Free Cash Flow | $24.6M | $24.6M | $-38.6M | $-10.0M | $-21.1M | $-18.2M |
| Returns | ||||||
| ROE | 1.7% | 1.7% | -56.9% | -23.5% | -9.6% | -9.9% |
| Valuation | ||||||
| EV/EBITDA | 2.74 | 2.74 | — | — | 89.81 | — |
| P/B | 0.63 | 0.63 | 0.52 | 0.29 | 2.29 | 3.40 |
| Growth & Yield | ||||||
| Revenue Growth | -5.0% | -5.0% | 5.3% | 15.1% | — | — |
| EPS Growth | — | — | 67.1% | -919.7% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+7.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.11 → n/d
Residual
+7.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.